X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Recent Patents on Anti-Cancer Drug Discovery

期刊標題檢索 RECENT PAT ANTI 最新評論: The manuscript submitted at the end of September last year took about ... (2024-08-27)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Recent Patents on Anti-Cancer Drug Discovery]您好,您是該頁面的第 23019 位訪客。

期刊簡介
期刊名稱Recent Patents on Anti-Cancer Drug Discovery Recent Patents on Anti-Cancer Drug Discovery
LetPub Score
5.1
50 ratings
Rate

Reputation
6.3

Influence
3.8

Speed
7.0

期刊簡稱RECENT PAT ANTI-CANC
ISSN1574-8928
E-ISSN2212-3970
h-index36
CiteScore
CiteScoreSJRSNIPCiteScore Rank
4.500.5400.442
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Pharmacology (medical)
Q2111 / 272
Category: Medicine
Subcategory: Oncology
Q2183 / 404
Category: Medicine
Subcategory: Drug Discovery
Q386 / 157
Category: Medicine
Subcategory: Cancer Research
Q3139 / 230

自引率 (2023-2024)4.00%自引率趨勢
掲載範囲
Aims & Scope

Recent Patents on Anti-Cancer Drug Discovery publishes review and research articles that reflect or deal with studies in relation to a patent, application of reported patents in a study, discussion of comparison of results regarding application of a given patent, etc., and also guest edited thematic issues on recent patents in the field of anti-cancer drug discovery e.g. on novel bioactive compounds, analogs, targets & predictive biomarkers & drug efficacy biomarkers. The journal also publishes book reviews of eBooks and books on anti-cancer drug discovery. A selection of important and recent patents on anti-cancer drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-cancer drug design and discovery. The journal also covers recent research (where patents have been registered) in fast emerging therapeutic areas/targets & therapeutic agents related to anti-cancer drug discovery.
官方網站http://www.recentpatentsonanticancerdrugdiscovery.com/
在線稿件提交http://bsp-cms.eurekaselect.com/index.php/PRA/login?source=%2Findex.php%2FPRA
開放訪問No
出版商Bentham Science Publishers B.V.
主題領域医学
出版國/地區U ARAB EMIRATES
發行頻率年3回刊行
創刊年2006
每年文章數38每年文章數趨勢
黃金OA百分比0.00%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ3183/322
PHARMACOLOGY & PHARMACYSCIEQ3180/354
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1574-8928%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: About 3.0 month(s)
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【Recent Patents on Anti-Cancer Drug Discovery】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    PHARMACOLOGICAL REVIEWSH-index: 210

    CiteScore: 34.70
    DRUG RESISTANCE UPDATESH-index: 100

    CiteScore: 26.20
    ADVANCED DRUG DELIVERY REVIEWSH-index: 278

    CiteScore: 28.10
    TRENDS IN PHARMACOLOGICAL SCIENCESH-index: 201

    CiteScore: 23.90
    PHARMACOLOGY & THERAPEUTICSH-index: 180

    CiteScore: 23.00
    MEDICINAL RESEARCH REVIEWSH-index: 119

    CiteScore: 29.30
    PHARMACOLOGICAL RESEARCHH-index: 118

    CiteScore: 18.70
    ARCHIVES OF PHARMACAL RESEARCHH-index: 75

    CiteScore: 13.40
    BIOMEDICINE & PHARMACOTHERAPYH-index: 78

    CiteScore: 11.90
    BRITISH JOURNAL OF PHARMACOLOGYH-index: 190

    CiteScore: 15.40
    學科內最受檢索的期刊 頁面查看次數
    BIOMEDICINE & PHARMACOTHERAPY498655
    PHYTOMEDICINE343697
    LIFE SCIENCES290241
    PHARMACOLOGICAL RESEARCH243471
    International Journal of Pharmaceutics242749
    European Journal of Pharmacology204544
    BIOCHEMICAL PHARMACOLOGY203056
    JOURNAL OF NATURAL PRODUCTS196864
    BRITISH JOURNAL OF PHARMACOLOGY165439
    MOLECULAR PHARMACEUTICS162981
  •  

    Recent Patents on Anti-Cancer Drug Discovery Recent Patents on Anti-Cancer Drug Discovery
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Recent Patents on Anti-Cancer Drug Discovery] 的評論撰寫評論
作者: fan@1225


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2024-08-27 22:56:49 評論於
The manuscript submitted at the end of September last year took about 3-4 months to be accepted, mainly because I wasted nearly a month due to some formatting issues after the acceptance was proposed. It should have been relatively easy to be accepted, with two reviewers providing feedback mainly on formatting issues, which were promptly addressed by the editor. However, since it is a quarterly journal, even though it was immediately indexed in PubMed at the time, it was not included in SCI until this month.
(0) 讚! | fan@1225

作者: 玄冰珠雨


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-21 19:53:20 評論於
Review speed: 6.0 | Submission hit rate: 95.0
Emphasis on research directions: Traditional Chinese medicine monomers; tumors; meta
Experience sharing: Traditional Chinese medicine monomers anti-tumor, submitted in February, accepted in June, the editor is very nice, formatting and layout are very important, language polishing is recommended "Researcher's Home".
(0) 讚! | 玄冰珠雨

作者: 罗汉子骞


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-25 16:15:20 評論於
Is there a requirement to provide a brief introduction of each author?
(0) 讚! | 罗汉子骞

作者: 回风念南


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-23 11:59:04 評論於
Please explain the review process, senior
(0) 讚! | 回风念南

作者: 残月东霞


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-19 17:59:06 評論於
Review speed: 3.0 | Submission acceptance rate: 50.0 Research focus: Anti-tumor experience sharing | Publication fee: $580
(0) 讚! | 残月东霞

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 18:48:34 評論於
The list of SCI journal rankings of the Chinese Academy of Sciences is still an essential reference directory for research performance rewards and title evaluations for many universities and research institutions in China
(0) 讚! | 维尔娜菲茨杰拉德

作者: 龙鳞孝礼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-29 15:09:58 評論於
There are many journal classifications, how to choose the right journal?
(0) 讚! | 龙鳞孝礼

作者: 修然小公主


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 11:37:52 評論於
Is it necessary to consider zoning when selecting publications?
(0) 讚! | 修然小公主

作者: Jason Chen


領域: 医学
審稿時間: 2.0 month(s)
結果: 直接被接受


撰寫評論

2021-01-17 06:11:28 評論於
We recently wrote and submitted an article reviewing natural products for cancer treatment. After making a few minor revisions, it was accepted. I was informed that they also accept case reports.
(4) 讚! | Jason Chen

作者: 东京千霜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-05-04 23:49:32 評論於
Review speed: 1.0
Experience sharing: I would like to let you guys know that the new editor-in-chief is not from Pakistan, instead, he is a Chinese in USA. Welcome to submit articles to this journal!
(0) 讚! | 东京千霜

作者: Hyman Jefferson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-05-04 13:36:58 評論於
Review Speed: 1.0 Experience Sharing: I had submitted two papers to this journal, and each time, it takes about one month for the review process
(0) 讚! | Hyman Jefferson

作者: Jason Chen


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2020-05-04 05:20:06 評論於
I would like to let you guys know that the new editor-in-chief is not from Pakistan, instead, he is a Chinese in USA. Welcome to submit articles to this journal!

(2) 讚! | Jason Chen

作者: Jason Chen


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2020-05-04 00:27:14 評論於
I had submitted two papers to this journal, and each time, it takes about one month for review process.

(0) 讚! | Jason Chen

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-18 16:32:17 評論於
The past was good, but now it's so frightening to see it fall so low. I want to get back to a 3-point level next year, but it might be really difficult
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2012-11-28 10:54:46 評論於
Can we reach 3 points next year? Let's discuss
(0) 讚! | 凌霄高洁

作者: 匿名


領域: 抗癌药物制剂
審稿時間: 0.0 month(s)
結果:


撰寫評論

2011-03-06 19:32:00 評論於
At the time, our research team received a letter of invitation from the journal. The editor of the journal is very responsible, the editor will send you some related patents for your reference. In addition, I submitted in mid-January 2009, and I received a revised opinion in mid-March, indicating that it can be published after minor repairs.

(1) 讚! | 匿名

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Recent Patents on Anti-Cancer Drug Discovery] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*